Pathstone Holdings »

Madrigal Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 4.7k 582.34
2025-09-30 $1.1M 2.4k 458.66

More positions owned by Pathstone Holdings

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Crowdstrike Hldgs Cl A (CRWD)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Pathstone Holdings

Top funds holding Madrigal Pharmaceuticals

Baker Bros. Advisors
Rtw Investments
Henderson Group
Vanguard Group
venBio Select Advisor
Paulson & Co
BlackRock
State Street Corporation
Geode Capital Management
Wellington Management Company
FMR
Invesco
William Blair Investment Management
Goldman Sachs Group
Susquehanna International

View all funds holding Madrigal Pharmaceuticals